We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.97B
AUM Growth
+$203M
Cap. Flow
+$159M
Cap. Flow %
8.06%
Top 10 Hldgs %
32.42%
Holding
162
New
22
Increased
42
Reduced
69
Closed
28

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$28M
2
COUR icon
Coursera
COUR
+$20.3M
3
PINC
Premier
PINC
+$18.6M
4
LYFT icon
Lyft
LYFT
+$18.3M
5
PYPL icon
PayPal
PYPL
+$16.9M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$39M
2
DBX icon
Dropbox
DBX
+$30.5M
3
VNT icon
Vontier
VNT
+$24.8M
4
FISV
Fiserv Inc
FISV
+$16.2M
5
FFIV icon
F5
FFIV
+$15.6M

Sector Composition

Rank Sector Weight
1 Technology 26.57%
2 Communication Services 12.72%
3 Healthcare 12.33%
4 Consumer Discretionary 10.59%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROVR
76
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$6.49M 0.33%
1,321,728
-1,177,464
-47% -$5.39M
NGD
77
DELISTED
New Gold Inc
NGD
$6.43M 0.33%
5,958,270
+1,364,744
+30% +$1.69M
EQC
78
DELISTED
Equity Commonwealth
EQC
$6.21M 0.31%
306,551
-188,128
-38% -$3.89M
CXW icon
79
CoreCivic
CXW
$3.19B
$5.79M 0.29%
614,929
-426,826
-41% -$3.87M
IIIN icon
80
Insteel Industries
IIIN
$625M
$5.7M 0.29%
183,189
-1,689
-0.9% -$50K
MD icon
81
Pediatrix Medical
MD
$2.2B
$5.69M 0.29%
400,218
-13,705
-3% -$192K
SEAT icon
82
Vivid Seats
SEAT
$85.4M
$5.32M 0.27%
33,570
+207
+0.6% +$32.3K
RJF icon
83
Raymond James Financial
RJF
$34B
$5.09M 0.26%
49,016
-32,261
-40% -$3M
T icon
84
CALL
AT&T
T
$163B
$4.57M 0.23%
286,700
SD icon
85
SandRidge Energy
SD
$503M
$4.54M 0.23%
297,733
-26,992
-8% -$396K
WRK
86
DELISTED
WestRock Company
WRK
$4.52M 0.23%
155,374
+110,898
+249% +$3.22M
SAMG icon
87
Silvercrest Asset Management
SAMG
$79.9M
$4.48M 0.23%
221,011
-109,572
-33% -$2.1M
GEN icon
88
Gen Digital
GEN
$17.5B
$4.47M 0.23%
240,880
-20,922
-8% -$366K
INGN icon
89
Inogen
INGN
$164M
$4.38M 0.22%
379,254
-141,098
-27% -$1.66M
WABC icon
90
Westamerica Bancorp
WABC
$1.37B
$4.3M 0.22%
+112,178
New +$4.49M
EQX icon
91
Equinox Gold
EQX
$13.5B
$4.28M 0.22%
934,792
-63,594
-6% -$319K
SON icon
92
Sonoco
SON
$5.74B
$3.99M 0.2%
67,620
-6,895
-9% -$415K
EGHT icon
93
8x8 Inc
EGHT
$332M
$3.93M 0.2%
+928,670
New +$3.35M
CSTL icon
94
Castle Biosciences
CSTL
$979M
$3.83M 0.19%
278,818
+191,566
+220% +$3.88M
MATV icon
95
Mativ Holdings
MATV
$711M
$3.79M 0.19%
+250,544
New +$4.43M
SPH icon
96
Suburban Propane Partners
SPH
$1.18B
$3.69M 0.19%
249,507
-11,305
-4% -$171K
FORR icon
97
Forrester Research
FORR
$224M
$3.62M 0.18%
124,313
-14,986
-11% -$446K
TASK icon
98
TaskUs
TASK
$669M
$3.6M 0.18%
+318,293
New +$3.87M
WHR icon
99
Whirlpool
WHR
$2.82B
$3.41M 0.17%
22,941
+12,478
+119% +$1.71M
WBA
100
DELISTED
Walgreens Boots Alliance
WBA
$3.4M 0.17%
119,202
-11,570
-9% -$377K

Similar funds

Invenomic Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Invenomic Capital Management held 162 positions worth $1.97B, up 11% from $1.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Invenomic Capital Management deployed $159M of net new capital in Q2 2023, opening 22 new positions and adding to 42 existing holdings. Its largest new stake was Citigroup: 596,817 shares worth $27.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Dropbox, an estimated $30.5M trimmed.

  • Invenomic Capital Management's largest Q2 2023 buy was Citigroup: 596,817 shares worth $27.5M.
  • Invenomic Capital Management added most to Coursera in Q2 2023, an estimated $20.3M increase.
  • Invenomic Capital Management's biggest Q2 2023 reduction was Dropbox, cutting an estimated $30.5M.
  • Invenomic Capital Management fully exited Meta Platforms (Facebook) in Q2 2023, selling an estimated $39M.
  • Invenomic Capital Management's ten largest holdings make up 32% of its $1.97B portfolio in Q2 2023.
  • Invenomic Capital Management opened 22 new positions and closed 28 in Q2 2023.
  • Invenomic Capital Management's portfolio value rose 11% quarter-over-quarter to $1.97B.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.